FDA grants breakthrough designation for Tecentriq + Avastin as first-line treatment for hepatocellular carcinoma

In the Headlines: Could “flooding the zone” drown NIH and cancer centers?

With a growing backlog at NIH and Columbia University’s grants getting canceled over alleged antisemitism, where does that leave NCI-designated cancer centers?

March 19, 2025

Vol.51 No.10

Podcast The Directors

The Directors: Ray DuBois and Roy Jensen on how COE guides cancer care in rural America
“We’re just going to have to ride through this and not give up.”

How are cancer centers in two rural states—Kansas and South Carolina—weathering the challenges of Trump-era belt-tightening and uncertainty? Their directors weigh in on The Cancer Letter Podcast.

Backlog of work grows at NIH as staff members are being hounded to quit

Government work isn’t what it used to be.

March 14, 2025

Vol.51 No.10

By Paul Goldberg, Jacquelyn Cobb and Claire Marie Porter

Guest Editorial

Rathmell: My mentor recognized a cliff I was going to fall off before I did.
“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.”

I was really excited to get to talk about the role that mentorship plays in women’s leadership development. It’s a topic that I’ve thought a lot about, and also that I’ve benefitted from, and that I think is not always applied with enough intention. There is an art to mentorship, and I want to share some of how that has helped me navigate career transitions and pivot to leadership roles.

March 14, 2025

Vol.51 No.10

By W. Kimryn Rathmell

Guest Editorial

In support of three coordinated CCSG components reducing our national burden of cancer

As we are all aware, the new presidential administration is moving rapidly to change how science, including health sciences, will be conducted and funded by the federal government, including research supported by the National Institutes of Health.

March 14, 2025

Vol.51 No.10

By Shine Chang, Michaela A. Dinan and Miria Kano

Guest Editorial

New drugs don’t appear out of thin air

As a physician-scientist who has navigated drug development from lab bench to bedside to executive boardroom, I want to touch upon a subject that is near and dear to my heart: the state of American science—a linchpin of our healthcare system and national competitiveness.

March 14, 2025

Vol.51 No.10

By William Pao

FDA grants breakthrough designation for Tecentriq + Avastin as first-line treatment for hepatocellular carcinoma

YOU MAY BE INTERESTED IN

In the Headlines: Could “flooding the zone” drown NIH and cancer centers?

The Directors: Ray DuBois and Roy Jensen on how COE guides cancer care in rural America
“We’re just going to have to ride through this and not give up.”

Backlog of work grows at NIH as staff members are being hounded to quit

Rathmell: My mentor recognized a cliff I was going to fall off before I did.
“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.”

In support of three coordinated CCSG components reducing our national burden of cancer

New drugs don’t appear out of thin air

Renew today!

Subscriber content

FDA grants breakthrough designation for Tecentriq + Avastin as first-line treatment for hepatocellular carcinoma

YOU MAY BE INTERESTED IN

In the Headlines: Could “flooding the zone” drown NIH and cancer centers?

The Directors: Ray DuBois and Roy Jensen on how COE guides cancer care in rural America“We’re just going to have to ride through this and not give up.”

Backlog of work grows at NIH as staff members are being hounded to quit

Rathmell: My mentor recognized a cliff I was going to fall off before I did.“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.”

In support of three coordinated CCSG components reducing our national burden of cancer

New drugs don’t appear out of thin air

The Directors: Ray DuBois and Roy Jensen on how COE guides cancer care in rural America
“We’re just going to have to ride through this and not give up.”

Rathmell: My mentor recognized a cliff I was going to fall off before I did.
“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.”